NCT05324956

Brief Summary

If the bone mineral density of a patient with a diagnosis of osteopenia falls further, he develops osteoporosis.Menopause causes many changes in women's bodies in the form of vasomotor, sleep disorders, fatigue, aches and pains, altered cognitive functions, as well as genitourinary problems such as vaginal dryness, irritation, recurrent urinary tract infections. In the long term, inevitable changes occur in the musculoskeletal system. Osteoporosis, sarcopenia, postural dysfunction, regression in gait cycle, Loss of balance control and instability and increased risk of falling are the changes reported during this period. These mentioned effects negatively affect the quality of life of women. The aim of this study is to investigate the relationship of bone mineral density with respiratory functions and exercise capacity in postmenopausal women.The second aim is to compare the respiratory functions and exercise capacities of postmenopausal women with osteopenia and osteoporosis.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 22, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

April 1, 2022

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2022

Completed
12 days until next milestone

First Posted

Study publicly available on registry

April 13, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2022

Completed
Last Updated

April 13, 2022

Status Verified

April 1, 2022

Enrollment Period

Same day

First QC Date

February 22, 2022

Last Update Submit

April 9, 2022

Conditions

Keywords

OsteopeniaOsteoporosisSpirometry6 Minute Walk TestNew York Posture Rating Chart

Outcome Measures

Primary Outcomes (3)

  • Evaluation of Respiratory Functions

    Spirometry will be applied to evaluate respiratory functions.It is the most commonly performed lung function test, which evaluates volume against time using a device called a spirometer. The expiratory time should be at least 6 seconds and extended up to 15 seconds if necessary.The patient is instructed to take a deep breath and blow as hard and as fast as possible and take a deep breath to complete the flow volume cycle. The one with the highest values out of at least three tests done in succession is selected.

    at baseline

  • Evaluation of Exercise Capacity

    6 Minutes Walking Test will be applied to evaluate exercise capacity. The goal of this test is to walk the maximum distance that can be walked in 6 minutes. Average walking distances: 20/50 age:590-640m 60/70 age:540/570m 70/80 age:470-530m.

    at baseline

  • Posture Assessment

    Posture assessment will be made using the New York Posture Rating Chart (NYPR).NYPR is an inexpensive, easy and fast-applied subjective postural assessment method that is widely used for clinical postural assessment. The grading chart is used to evaluate 13 areas of the body based on the assumption that posture is the alignment of the body and its parts.Each field is awarded a point based on position: 5 points for correct position; 3 points for a slight deviation and 1 point for a significant deviation. The total score ranges from 18-90 points. The higher the score, the better the postural alignment.

    at baseline

Study Arms (1)

Postmenopausal Women

Postmenopausal women be between 40-79 years and being diagnosed with osteoporosis or osteopenia

Other: No intervention

Interventions

Individuals will not receive any interventions

Postmenopausal Women

Eligibility Criteria

Age40 Years - 80 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Postmenopausal women aged between 40-80 years old and diagnosed with osteoporosis or osteopenia

You may qualify if:

  • Between 40-80 years old
  • Female gender
  • Being diagnosed with menopause
  • Being diagnosed with osteoporosis or osteopenia
  • Volunteer to participate in the study

You may not qualify if:

  • Hemoptysis of unknown cause
  • Recent abdominal, thoracic, or eye surgery
  • Thoracic, abdominal, or cerebral aneurysm
  • pulmonary embolism
  • Mental state disorder that interferes with cooperation
  • Arrhythmias disrupting hemodynamics
  • Having any diagnosed disease affecting the respiratory system
  • pneumothorax
  • unstable angina
  • Recent myocardial infarction
  • Thrombosis in lower extremity
  • Acute myocarditis
  • Other diseases that will prevent exercise (infection, kidney failure)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Öykünur CANSU

Izmir, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Bone Diseases, MetabolicOsteoporosis

Condition Hierarchy (Ancestors)

Bone DiseasesMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic Diseases

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

February 22, 2022

First Posted

April 13, 2022

Study Start

April 1, 2022

Primary Completion

April 1, 2022

Study Completion

June 1, 2022

Last Updated

April 13, 2022

Record last verified: 2022-04

Locations